Eneko Ganuza serves as the Vice President of Research and Development at iWi/Qualitas Health, where he is at the forefront of innovation in the microalgae industry. With a robust background as a research microbiologist, Eneko is dedicated to advancing the development of sustainable and scalable...
Eneko Ganuza serves as the Vice President of Research and Development at iWi/Qualitas Health, where he is at the forefront of innovation in the microalgae industry. With a robust background as a research microbiologist, Eneko is dedicated to advancing the development of sustainable and scalable solutions that harness the potential of microalgae for nutritional applications. His expertise spans various cultivation systems, including photoautotrophic, mixotrophic, and heterotrophic methods, allowing for a versatile approach to optimizing biomass production and bioactive compound extraction.
At iWi, Eneko is spearheading key projects aimed at enhancing the efficacy and sustainability of existing products while paving the way for future innovations. His leadership in R&D is crucial as the company strives to build a comprehensive platform that addresses global nutritional needs while remaining committed to environmental stewardship. By leveraging advanced techniques such as High-Performance Liquid Chromatography (HPLC), Polymerase Chain Reaction (PCR), and process simulation, Eneko and his team are exploring novel pathways for the production and transformation of bioactive products derived from microalgae.
Eneko’s passion for microbial systems and their applications in food and health underscores his commitment to research and product development. His work not only contributes to the scientific community but also aligns with iWi’s mission to create a healthier planet through innovative algae-based nutrition. As he continues to drive R&D strategies, Eneko is poised to make significant contributions to the field, ensuring that iWi remains a leader in sustainable nutrition solutions.
